Viewing Study NCT00047333


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-05-26 @ 9:48 PM
Study NCT ID: NCT00047333
Status: TERMINATED
Last Update Posted: 2013-01-23
First Post: 2002-10-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Primary Hepatocellular Carcinoma View
None Advanced Adult Primary Liver Cancer View
None Localized Unresectable Adult Primary Liver Cancer View
Keywords: